Center For Financial Planning, Inc. Crispr Therapeutics Ag Transaction History
Center For Financial Planning, Inc.
- $869 Million
- Q2 2025
A detailed history of Center For Financial Planning, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 10 shares of CRSP stock, worth $701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$701
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
532Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$715 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$393 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$259 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$230 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$200 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.48B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....